EXECUTIVE DIRECTORS

LI Xinzhou (李新洲), is our chairman and executive Director. Mr. Li is the founder of the Group and joined Pioneer Pharma Shareholding Company Limited (“Pioneer Pharma”), our initial corporate entity, in July 1996 as its general manager and chairman, responsible for managing the operations and planning and formulating the Group’s strategies. Mr. Li has over 28 years of experience in the pharmaceutical services industry. Under Mr. Li’s leadership, our Group has received numerous awards and recognitions. Mr. Li is a director of Pioneer Pharma (BVI) Co., Ltd. and Tian Tian Limited, each being a substantial shareholder of the Company.

Mr. Li has over 26 years of experience in international trading and management. Prior to joining the Group, Mr. Li worked at the Hainan branch of Sumitomo Corporation. From August 1984 to August 1988, Mr. Li worked as an English translator in China Offshore Oil Nanhai West Corporation (中海油南海西部公司) and from July 1981 to August 1984, he worked as an English teacher at Jianghan Oil Field Dongfanghong High School (江漢油田東方紅學校). Mr. Li has also held various positions in trade associations. He was the vice chairman of the Hainan General Chamber of Commerce (海南省總商會) and the standing vice president of Hainan Hubei Chamber of Commerce (海南省湖北商會). He has also served as a member of the Chinese People’s Political Consultative Conference Hainan Committee (海南省政協). Mr. Li graduated from Jianghan Petroleum Normal School (江漢石油師範學校) with a diploma in English in July 1981. He also studied at the China Europe International Business School (中歐國際工商學院). Mr. Li is also the chairman of the Nomination Committee.

YANG Yuewen (楊悅文), is our executive Director. Mr. Yang joined the Group in September 2016 and worked as product manager, marketing manager and the general manager of the AW business unit and was responsible for the promotion and sales of Alfa Sigma’s products and NovaBay’s products from September 2016 to January 2022. In January 2022, he was appointed as the chief operating officer of the Group. Prior to joining the Group, Mr. Yang worked at Novartis pharma limited and AstraZeneca pharma limited and was responsible for marketing in the CV area. Mr. Yang graduated from Jiangxi University of Chinese Medicine with a bachelor’s degree in pharmaceutical engineering in June 2010 and graduated from Jiangxi University of Chinese Medicine with a master’s degree in pharmaceutical chemistry in June 2013 (the major was a joint training program between China State Institute of Pharmaceutical Industry and Jiangxi University of Chinese Medicine).

Zhang Quan (張權), is the general manager of the dental business division of the Group.Mr. Zhang started cooperation with the Group as a consultant of the dental business divisionin March 2020, and worked as the regional sales manager of the dental business divisionof the Group since March 2021. He was appointed as the general manager of the dentalbusiness division of the Group on 30 August 2021, in charge of the marketing and sales ofIvoclar Vivadent Zenostar (WIELAND ZENOSTAR) and Korea’s DMAX series zirconiaproducts, of which the dental business division is the agent. Mr. Zhang has been in the salesof dental-related materials since 1993, and from 1994 to 2020, he worked for Dentsply Dental(Tianjin) Trading Co., LTD, Soundwatch (Siemens) Hearing Services LTD, Sirona DentalSystems (Shanghai) Trading Co., LTD and Ivoclar Vivadent (Shanghai) Trading Co., LTD,having nearly 30 years of marketing/sales experience in dental business. Mr. Zhang graduatedfrom Beijing Institute of Civil Engineering and Architecture with a major in Industrial andCivil Architecture in June 1986.

NON-EXECUTIVE DIRECTOR

HU Mingfei (胡明非), is a non-executive Director. Ms. Hu joined the Company in December 2020. Ms. Hu obtained the degrees of Bachelor of Law in 1986 and Master of Law in 2000 from Peking University. She was a visiting scholar to the European Union in 2000 and to the University of British Columbia in 2003. Ms. Hu is experienced in law and medical devices. She served in the Supreme People’s Court of the People’s Republic of China from 1986 to 2002 with her last duty as a judge (審判員), and in Beijing Vistek Medical Co, Ltd. from 2004 to 2019 with her last duty as Vice President and as Senior Consultant (高級顧問) to Shanghai Xinlang Medical Co., Ltd. (上海鑫朗醫療器械有限公司) from 2019 to 2020. Ms. Hu is a member of the Audit Committee and a member of the Remuneration Committee.

INDEPENDENT NON-EXECUTIVE DIRECTORS

ZHANG Hong (張虹), is our independent non-executive Director. Mr. Zhang joined our Company in January 2019. Mr. Zhang is an expert in public security governance. Prior to joining the Group, he served in a shipping organisation in the PRC for 38 years since 1980. He held various senior positions at such organisation, and was mainly responsible for handling legal matters and administration management. From 1982 to 1999, Mr. Zhang pursued his studies at Hubei University and other Institutions, in the areas of law, administrative management, corporate management, as well as economics and management. Mr. Zhang is the chairman of the Remuneration Committee, a member of the Audit Committee and a member of the Nomination Committee.

LAI Chanshu (賴展樞), is our independent non-executive Director. Mr. Lai joined our Company in December 2021. He has over 45 years of experience in the pharmaceutical industry. He worked at the marketing and sales department for the Taiwan branch of Merck Sharp & Dohme (默沙東藥廠) during the period from September 1972 to December 1974. He worked as the general manager of the Taiwan market at Alcon Pharmaceuticals Ltd. (愛爾康藥品（股 份）公司) from January 1975 to February 2002. He was the general manager of logistics and management at Taiwan De Hua Pharmaceuticals Ltd. (台灣德樺藥品股份有限公司) from March 2002 to May 2008. Mr. Lai was an independent non-executive Director of the Company from October 2013 to December 2018. Before rejoining the Company, he is the lead consultant of the China and Taiwan market at Kim Huc Trading and Consultant Co., Ltd. (金旭貿易暨諮詢責任有限公司) from March 2019. Mr. Lai graduated from Taipei Medical University (臺北醫學大學) with a bachelor’s degree in pharmacy in June 1971. He has been a pharmacist registered with the Department of Health of the Republic of China (中華民國行政院衛生署) since April 1972. Mr. Lai is a member of the Nomination Committee and a member of the Remuneration Committee.


Zhang Changhai, aged 50, is a Professorate Senior Accountant, doctoral supervisor, Certified Public Accountant and a member of the Association of International Accountant (AIA). Mr. Zhang has nearly 30 years of working experience in the field of auditing and accounting, and was the 2022 National Accounting Advanced Worker (2022年全國會計先進工作者). He worked as a professor of accounting in the Management School and the deputy director of the Department of Accounting of Hainan University from January 2013 to September 2014; from October 2014 to May 2022, he worked as the deputy director and director of the Finance Office, professor of accounting and doctoral supervisor of Hainan University; from June 2022 to December 2023, he worked as the secretary of the Party Committee of Civil Engineering and Architecture School of Hainan University; and since December 2023, he worked as the professor of accounting and doctoral supervisor of International Business School of Hainan University. Mr. Zhang holds a bachelor’s degree in economics and a master’s degree in management and received a doctorate degree in management from Jinan University. Mr. Zhang has also participated in the continuous professional education for Certified Public Accountants every year since 2000.